SCHEMBL8300272

SCHEMBL8300272

CCCCOC(=O)N1CCC2CC(O)CCC2C1C(=O)OCC

nearest known ligand 0.36

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
GBA2 Q9HCG7 1/20 0.36
LMNA P02545 1/20 0.35
POLB P06746 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
DPP4 P27487 1/20 0.32
MAPT P10636 3/20 0.31
CYP3A4 P08684 2/20 0.31
IDH1 O75874 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27334025 0.86 CYP3A4 (0.36) MAPTCYP3A4
SCHEMBL10474713 0.83 CHRM2 (0.37) POLBMAPTCYP3A4
SCHEMBL31078958 0.79 DPP4 (0.42) GBA2LMNAPOLBSMN1; SMN2DPP4
SCHEMBL15715693 0.76 GBA2 (0.47) GBA2LMNAPOLBSMN1; SMN2
SCHEMBL27524171 0.75 GAA (0.36) LMNASMN1; SMN2DPP4MAPTCYP3A4
SCHEMBL17154832 0.75 LMNA (0.43) GBA2LMNAPOLBSMN1; SMN2
SCHEMBL28383221 0.72 SMN1; SMN2 (0.43) GBA2LMNAPOLBSMN1; SMN2DPP4
SCHEMBL4632458 0.71 SMN1; SMN2 (0.42) GBA2LMNAPOLBSMN1; SMN2DPP4
SCHEMBL6819738 0.71 GBA2 (0.45) GBA2LMNAPOLBSMN1; SMN2MAPT
SCHEMBL6052893 0.71 GBA2 (0.45) GBA2LMNAPOLBSMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0658545-B1 Decahydro-isoquinoline derivatives LILLY CO ELI (US) 1999-09-29 EP disclosed
EP-0383504-B1 Decahydro isoquinoline derivatives, process for their preparation and use as medicines LILLY CO ELI (US) 1995-07-19 EP disclosed
EP-0658545-A1 Decahydro-isoquinoline derivatives ELI LILLY AND COMPANY (US) 1995-06-21 EP disclosed
EP-0383504-A2 Decahydro isoquinoline derivatives, process for their preparation and use as medicines ELI LILLY AND COMPANY (US) 1990-08-22 EP disclosed